ARTICLE | Clinical News
Gensia regulatory update
November 24, 1997 8:00 AM UTC
GNSA's Gensia Laboratories Ltd. subsidiary (Irvine, Calif.) received ANDA approval from the FDA for bumetanide injection for the acute treatment of edema associated with congestive heart failure and h...